PMDA — authorised 23 March 2018
- Marketing authorisation holder: Takeda Pharmaceutical Company Limited
- Status: approved
PMDA authorised Azilect on 23 March 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 March 2018.
Takeda Pharmaceutical Company Limited holds the Japanese marketing authorisation.